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 Sepsis is a time-sensitive condition in which fast and accurate diagnosis is 
beneficial to patients. The current gold standard in diagnosing sepsis requires plating a 
sample from a positive blood culture in order to isolate bacteria for further testing. This 
sub-cultivation step requires on average 18 hours of incubation to grow a sufficient 
number of bacteria colonies, therefore introducing a delay to perform downstream tests. 
However, the replacement of this step with a faster method will allow clinicians to 
identify the responsible pathogen and administer the appropriate antibiotics sooner. To 
reduce time to results, a method based upon tangential flow filtration was developed to 
isolate viable bacteria from a positive blood culture in a matter of minutes. This method 
produces a bacteria suspension that excludes blood cells and analytes, allowing the 
sample to be used in subsequent identification and antimicrobial susceptibility testing. By 
eliminating the subcultivation step, patients can receive optimized treatment earlier, 
which is correlated with positive clinical outcomes.  
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Sepsis, a systemic inflammatory response to infection, causes more than 751,000 
hospitalizations and 215,000 deaths in the United States annually,1 with the number of 
cases increasing by 13.7% each year.2 Severe sepsis is reported in 2% of patients 
admitted to the hospital, of which half are treated in the ICU, representing 10% of all ICU 
admissions3 and costing $17 billion in annual health care expenses. 
Signs of a systemic inflammatory response, such as faster heart beat (tachycardia) 
or an elevated white blood cell count, can occur in many infectious and noninfectious 
conditions, so they may not help to differentiate sepsis from other conditions. One of the 
main defining characteristics of sepsis is the presence of microorganisms in the blood, in 
addition to other clinical symptoms for Systemic Inflammatory Response Syndrome 
(SIRS), as listed in Table 1.4 Sepsis can evolve into severe sepsis when it is complicated 
by acute organ dysfunction and further progress to septic shock when sepsis is 
accompanied by either persistent hypotension or hyper-lactatemia.5,6 A summary of the 
stages of sepsis is outlined in Table 1 below. Severe sepsis can be acquired from both 
community and health care-associated infections, with pneumonia as the most common 
cause, accounting for about half of all cases, followed by intra-abdominal and urinary 
tract infections.3  The most common isolates responsible for infection, such as 











Figure 1. Top 20 microbes identified from positive blood cultures during 2013 in a 
tertiary-care university hospital. The pie chart represents the distribution per morphotype 




Sepsis diagnostics: state of the art 
Once a patient is suspected of having sepsis, the clinician is responsible for 
forming a plausible diagnosis, obtaining blood cultures, and administering empirical 
antimicrobial therapy. A rapid assessment can be made based on the patient’s history and 
clinical symptoms presented. Clinicians will administer a set of broad spectrum 
antibiotics prior to the precise diagnosis since early appropriate antibiotics are associated 
with improved survival. The choice of initial empirical antibiotic therapy depends on the 
likely source of infection, the most likely pathogens involved and related susceptibility 
profiles.6 Then, investigations to confirm the presence, source and severity of the 
infection need to be performed to refine diagnosis and treatment.  
Blood cultures are one of the most important clinical laboratory tests performed as 
the gold standard for diagnosing bloodstream infections (BSIs). The number of microbes 
present during BSIs range from 1 to 10 colony forming units (CFU) per mL of blood, and 
these bacteria are allowed to grow in cultivation media.8 Once the blood culture bottle 
goes “positive”, indicating that bacteria growth is detected, Gram staining is performed 
which determines the morphotype of the bacteria (Gram-positive or Gram-negative) and 
allows for the first adjustment of antibiotic therapy. In some cases, the blood culture may 
be polymicrobial instead of monomicrobial, such that both Gram-negative and Gram-
positive organisms are present. Polymicrobial BSIs encompass approximately 6 – 32% of 
all BSI episodes.9 
Adjustment of antibiotic therapy is necessary to reduce the potential for antibiotic 
resistance and other side effects, such as increased risk for mortality, due to inappropriate 
antimicrobial treatment.10 Plating a sample of this positive blood culture (PBC), 
otherwise known as the subcultivation step, is then needed to isolate the bacteria for 
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identification (ID) and antimicrobial susceptibility testing (AST). Isolation of the bacteria 
from PBC is needed for faster ID using matrix-assisted laser desorption/ionization-time 
of flight mass spectrometry (MALDI-TOF MS). ID straight from blood culture is 
possible but yields spectra of lower quality than those from colonies, sometimes making 
it difficult to differentiate between closely related species.11,12 Excellent spectra are 
obtained when a minimum of 106 CFU are spotted onto the MALDI target plate, which is 
a concentration easily obtained from culture plates but at the threshold of what is 
normally present in a PBC bottle. Inadequate spectra are usually the result of an 
insufficient amount of bacteria on the target plate.13 Furthermore, bacteria isolates are 
needed to accurately inoculate a known bacteria concentration into AST systems. AST 
systems such as the BD Phoenix system will notify the clinician what drugs (and at what 
dose) can be used to treat the patient. Identification of the bacteria is needed to interpret 
the antimicrobial profile results so that the clinician can make the appropriate changes 
and further deescalate antibiotic therapy.  
Currently, it takes up to 2 days or even longer for a septic patient to be thoroughly 
tested and diagnosed. Figure 2 outlines the basic workflow starting from when a patient 
presents clinical symptoms of sepsis to the final stages when an accurate and complete 
diagnosis is made. The median time to detect a positive blood culture is approximately 12 
hours but may be longer or shorter. 14 One of the most time consuming steps is the 12-
 to 24-hour incubation period required for plating to obtain enough isolated colonies from 
a PBC for characterization. 8 The following results are obtained within an hour for ID and 
in 4-16 hours for AST. However, by that time the results are usually too late to influence 




phenotypic AST. Another subculture independent approach is to obtain a microbial pellet 
from a blood culture, such as through the Bruker’s MALDI Sepsityper. This method can 
be used with MALDI-TOF MS and provide ID results in less than an hour, but requires 
lysing of cells and multiple buffer washing steps with centrifugation. Therefore, this 
labor-intensive process will hinder their implementation into laboratories with limited 
human resources. In addition, using the produced bacteria pellet with AST systems is 
suboptimal because the lysing and centrifugation steps decrease the viability of the 
bacteria of interest, leading to discrepancies in results compared to conventional 
approaches.16 Stressed organisms may respond differently to antibiotics compared with 
those organisms that have been inoculated into the AST panel from subculture.18 
 
Clinical need  
To address increasing rates of drug resistance, clinicians are compelled to 
administer empiric broad-spectrum antibiotics to patients with presumed bacterial 
infection as soon as possible. However, the initial antimicrobial treatment used is an 
important determining factor of survival in patients with sepsis; inappropriate initial 
antibiotic treatment can increase mortality. Administration of effective antibiotics within 
the first hour of documented hypotension was associated with a survival rate of 79.9%. 
Furthermore, each hour of delay in antimicrobial administration in the following 6 hours 
was associated with an average decrease in survival by 7.6%.19 More importantly, de-
escalation of initial broad-spectrum therapy may prevent the emergence of resistant 
organisms and minimize the risk of drug toxicity.16 For those reasons, the time required 
to identify the bacteria and receive AST results has a critical influence on subsequent 
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therapy. In one study, reducing the turnaround time for results by almost a full day 
allowed for earlier adjustment of targeted antimicrobial therapy which correlated with 
positive clinical outcomes such as decreased length of stay, decreased mortality, and 
reduced health care expenditures.19,20 The important relationship between prompt 
administration of optimized antibiotic therapy and improved patient outcome highlights 
the advantage of shorter time to results. This project proposes to decrease time to results 
by addressing the subcultivation step which is time spent by waiting for pure bacteria 
isolates to grow. Replacing this conventional method with a quicker alternative to 













The primary goal of this project is to develop a rapid method to isolate viable 
bacteria from a mono-microbial PBC in order to replace the time-consuming 
subcultivation step. Replacing this conventional method, which takes on average 18 
hours, with a method that provides a bacterial isolate on the order of minutes, allows for 
reduced time to results. Consequently, clinicians can accurately diagnose septic patients 
and administer targeted antimicrobial therapy in a timely manner, ultimately improving 
patient outcome.  
The final output sample provided by this new PBC processing method needs to 
integrate with pre-existing ID and AST systems. To allow for accurate results, the 
isolated bacteria need to be relatively pure so that any blood cells or analytes that can 
interfere with subsequent testing are excluded. Also, the bacteria need to be viable and 
uncompromised in order to yield accurate AST results. Lastly, a final bacteria suspension 
ranging from 108 total CFU in 100 µL to 109 total CFU in 1 mL is required to provide 
sufficient bacteria sample to be tested in both ID and AST systems. For this project, the 
PBCs of interest are limited to mono-microbial PBCs because the separation of different 
bacterial species from each other introduces additional difficulties that can be addressed 








Table 2: Design constraints and targets for PBC processing method 
Specification Target  
Input PBC—monomicrobial, any media type, any bacterial species 
Output Viable bacteria isolates (at least 108 CFU in 100 µL or 109 in 1 mL) 
with minimal blood background contributing to optical density 
Compatibility Interfaces with both ID and AST systems  
Allows for Gram staining of bacteria suspension 
Time Less than 15 minutes to isolate bacteria from PBC 





















In tangential flow filtration (TFF), also known as cross-flow filtration, a pump 
drives the feed fluid from the retentate reservoir along the membrane, allowing the fluid 
to recirculate, while the same or different pump produces a transmembrane pressure 
(TMP) which draws the permeate across the membrane (Figure 3A). Components larger 
than the pore size are retained in the feed solution as the retentate while solutes smaller 
than the pore diameter will be collected in the permeate.22 As seen in Figure 3B, the feed 
suspension in TFF flows parallel to the filter membrane and perpendicular to the flow of 
filtrate. 23  The TFF system also allows for the addition of solvent during filtration to 
dilute the retentate as permeate is removed (Figure 3A).  
Another popular means of filtration is dead-end filtration, which is typically used 
as a single-pass method with a constant system pressure across the membrane to yield 
permeate. In this case, as seen in Figure 3C, the feed solution flows perpendicular to the 
filter membrane and the permeate flows straight through the membrane’s pores, resulting 
in a higher likelihood of particles clogging the pores. Therefore, dead-end filtration is an 
appropriate means to concentrate or separate particles in large sample volumes, but may 
not be as suitable for purification applications that require washing. 24  
For both tangential-flow and dead-end filtration, separation of molecules or 
particles from fluid poses a problem to the integrity of the filtration membrane over time 
due to fouling. The accumulation of particles on the membrane surface can be limited but 
unavoidable.25 In this application, a PBC containing blood cells, bacteria, cell debris, and 
other media components is filtered through a membrane. Although the hematocrit level is 
reduced five-fold compared to whole blood, there is a substantial number of blood cells 
left (about 108 cells/mL) and the bacteria have grown to reach a concentration of 107 –
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 109 CFU/mL. For TFF, as the fluid recirculates on the retentate side, the solutes are 
brought to the membrane surface, forming a layer of rejected solutes, which increase the 
resistance to filtration. Also, the TMP will further pack and condense this layer so that 
the membrane becomes increasingly less permeable as the pores are narrowed or blocked, 
and also less efficient in separating small solutes from larger ones in the retentate. 
Therefore, it is necessary to circulate the retentate at high enough speeds to generate a 
high enough shear rate to increase back transport away from the membrane, reduce 
concentration polarization, and limit cake formation on the membrane surface. By 
increasing the cross-flow velocity and the shear rate, the particles are carried away from 
the membrane and brought back to the bulk feed solution by tangential flow, forming a 
thinner cake layer.26 However, in unstirred dead-end filtration, the accumulation of 
solutes on the surface or inside the pores of the membrane will quickly decrease the 
permeation flux. Therefore, this process is only practical for microfiltration of low-
concentration fluids such as surface water. For TFF, continuous recirculation of feed and 
optimization of both the flow rate and TMP are able to control fouling. On the other 
hand, in dead end filtration, a batch filtration method, the system needs to be stopped for 
backwashing in order to remove any caking that may have occurred.22 
Membrane filtration can be operated in dead-end or cross-flow modes. The choice 
depends on the importance of productivity compared to operational costs. For solutions 
with high fouling potential, cross-flow filtration is necessary, but for feed solutions that 
are less likely to foul, dead-end filtration is usually more economical as a batch process. 
Since the retained particles continuously accumulate on the membrane surface during 
filtration, periodic backwashing is required to remove deposited particles. 27 For the 
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application of interest, TFF is a continuous process that is preferable for its ability to 
control fouling using the system parameters. Furthermore, the reduction in caking 
provided by TFF will help to maintain permeate flux, improve efficiency, and maximize 
bacteria recovery due to minimized adhesion of bacteria to the membrane.  
Hydrodynamic forces acting on blood components 
Blood is composed of RBCs, WBCs, platelets, and plasma, with the ratio of 
WBCs against RBCs to be 1:600-1,000. RBCs are biconcave disks and are known to be 
extremely deformable. The viscosity ratio between the inner fluid of the RBC and the 
carrier fluid can partly explain the behavior of RBCs in their environment. 28 At small 
shear rates and at rest, RBCs have a biconcave discoid shape; but at high shear rates, the 
cell shape adopts to the parabolic flow field and the cells become parachutes. 29–31  In 
Poiseuille flow with a parabolic flow profile, deformable RBCs will migrate away from 
the wall towards the center of the channel due to cell-wall interactions. This 
hydrodynamic lift force experienced by the RBCs is known as the Fåhræus-Lindqvist 
effect which also drives the WBCs and blood platelets to migrate towards the walls, due 
to a phenomenon known as margination.  
The hydrodynamic lift force is dependent on: shape of the particle, deformability 
of particle, density difference between the particle and fluid, and shear stress. 28,32 The 
typical size distribution of blood components and bacteria is outlined in Table 3. Since 
both RBCs and platelets are discoid shaped and have a soft membrane, their size 
difference affects their lift velocity; the larger RBCs experience a greater lift force and 
will migrate closer to the center of the channel. The stiffer and more rigid WBCs do not 




biopolymers are involved. The consequences of biofilm formation on membranes 
include: increased membrane resistance, decreased permeate production, increase of drag 
resistance to tangential flow, increased differential pressure, and concentrated 
populations of microorganisms on membrane surfaces. 34,35 Membrane fouling can be 
somewhat controlled by the selection of an appropriate membrane and adjustment of the 
operating conditions, but very often these are not enough to address all the sources of 
biofouling.  
As the bacteria approaches the surface of the membrane, there are several forces 
at work between the bacterial cell wall and the membrane. These forces include hydraulic 
forces, electrostatic forces, mechanical attachment with polymeric surface structures and 
hydrophobic interactions. Initially, the cell is only reversibly attached and can be 
removed by a change in shear force. However, after a certain amount of time, the bonds 
between the cell and membrane surface become more permanent. Some bacteria have 
surface appendages such as pili, or fimbriae, which anchor onto the membrane structure. 
The extra-cellular polymeric substance (EPS) secreted by the bacteria helps to form a 
polymer bridge between the cell and surface which becomes more stable over time. 36 
Membrane properties to address biofouling 
For the TFF system developed for this project, characteristics of the filter 
membrane can be modified to meet performance criteria and reduce biofouling.  
One main property that can be considered to reduce bacteria adhesion is the 
hydrophobicity of the membrane.  Fouling occurs more readily on hydrophobic surfaces 
because there are minimal hydrogen bonding interactions in the boundary layer between 
the membrane surface and water. Water molecules are repelled away from hydrophobic 
surfaces due to entropy, so foulant molecules can adsorb onto the surface more easily. 
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However, hydrophilic surfaces possess a high surface tension, allowing for the formation 
of hydrogen bonds with the surrounding water molecules and the construction of a thin 
water boundary between the membrane and bulk solution. Therefore, hydrophilic 
membranes are less susceptible to fouling with organic substances and microorganisms 
due to decreased interaction between the foulant and the membrane surface.36  
Membrane charge is an important factor to consider especially when foulants are 
charged. If the foulant and surface have similar charge, electrostatic repulsion forces 
between them will prevent the foulants from depositing onto the membrane. Bacterial 
surfaces are usually comprised of phospholipids, lipopolysaccharides, polysaccharides 
and proteins, which are all charged at physiological pH. They usually carry negative 
charges and thus negatively charged membrane surfaces are less prone to bio-adhesion. 
However, some studies have shown that there is increased bacterial adhesion to surfaces 
with increasing negative zeta potential due to the formation of a conditioning layer. 
Cations are readily adsorbed onto the surface, and can act as bridges between the 
membrane surface and the cell. Despite this fact, there is a much steeper increase in 
fouling for surfaces with a positive zeta potential compared to those with a negative zeta 
potential. There is also some research that suggests that the interfacial electrostatic 
repulsion of the material extends for a small distance compared to the typical bacteria pili 
that extend 500-1000 nm from the bacterial cell surface, so bacteria could potentially 
overcome this extent of electrostatic repulsion. 37  
Although trying to mitigate biofouling by membrane modification is beyond the 
scope of this project, it is an important factor to investigate as the project progresses. In 
addition to the surface membrane properties, membrane fouling also largely depends on 
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the concentration of bacteria, nutrients in the feed solution, and the hydrodynamic forces 
within the system.34 Optimization of operation conditions and feed solution along with 
targeted modification of surface properties should be able to minimize membrane 
biofouling.  
Track-etched membranes 
Polycarbonate track-etched membranes (TEMs) were chosen for their well-
controlled pore size and cylindrical holes. These qualities are preferable compared to 
other membrane types such as polytetrafluoroethylene and nylon which possess irregular 
tortuous paths for permeate to follow. 38 These polycarbonate membranes also have low 
non-specific binding and are biologically inert, which can potentially help reduce 
membrane fouling. The TEM starts out as a roll of plastic film, which is then exposed to 
charged particles from a nuclear reactor, leaving behind latent tracks. Next, the film is 
treated with a caustic etchant which preferentially targets the tracks to form pores. A 
unique property of TEMs is that the pore density and size can be modified independently 
of each other as they are controlled by exposure time, concentration of the etchant, and 
temperature. The pore diameter can range from 10 nanometers to tens of microns and the 
pore density can vary from 1 to 1010 cm-2.  Polycarbonate TEMs have a lower wettability 
compared to PET membranes, which is why a wetting agent, polyvinylpyrrolidone, is 









Test Samples  
Blood culture bottles (BACTEC Standard Aerobic culture vials) were spiked with 
10 mL of bagged human blood and 10-100 colony forming units (CFU) of the bacteria of 
interest (1 strain per bottle). The appropriate number of bacteria was inoculated into the 
blood culture bottle to reflect the expected concentration of bacteria in a patient's blood. 




Figure 5. Experimental Plan after creation of a PBC test sample. In the reference method, 
a sample of PBC was plated to grow bacteria isolates. In the experimental method, the 
PBC was filtered using the new PBC processing approach to yield an isolated bacterial 
suspension. A 0.25 McFarland suspension of the isolated bacteria samples was then 
inoculated into a Phoenix panel for AST. Plate counts were performed in parallel in the 





Plate counts  
Once the bottle was considered positive by the BACTEC instrument, it was 
removed and the initial bacteria concentration in the PBC was calculated by creating 
serial dilutions and inoculating TSA II 5% sheep blood plates with the sample.  In the 
experimental method, the output bacteria sample after filtration was serially diluted and 
plated. Once the organisms had grown on the plates overnight, plate counts were 
performed to calculate the recovery.   
Antimicrobial Susceptibility Testing 
The bacteria samples isolated from two different methods were tested using the 
BD Phoenix AST system. The system determined the susceptibility of the bacteria to 
various drugs and determined the minimum inhibitory concentration (MIC), the lowest 
concentration of drug that prevents visible growth of a bacteria. Organism identification 
was used in the interpretation of the MIC values of each antimicrobial agent producing 
Susceptible, Intermediate, or Resistant (SIR) result classifications.  
The Phoenix AST panel has growth control wells and wells with varying 
concentrations of antimicrobial agents.  Prior to inoculating the AST panel, a bacteria 
suspension of a known concentration was made. The bacteria suspension, isolated from 
either subcultivation or filtration, was measured for its turbidity, which is the cloudiness 
of the sample. The optical density of the bacteria suspension could be compared to a 
McFarland standard, a turbidity standard, which allows for estimation of organism 
concentrations. A nephelometer was used to measure the scattered light from the particles 
in suspension and determine the McFarland equivalent. The isolated bacteria were added 
to a Phoenix ID tube (2.2 mL fill volume) to achieve a 0.25-0.30 McFarland suspension, 
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and then 25µL of that suspension was added to AST broth for AST panel inoculation.  In 
this case, 0.25 McFarland is approximately 7.5 x 107 CFU/mL (based off of E. coli, 
ATCC 25922).  
The panels were inoculated with this standardized organism suspension and the 
system read panels every 20 minutes to determine bacteria growth. The AST results of 
the isolated bacteria from the two different methods, the reference method 
using subcultivation and the new PBC processing step, were compared. The experimental 
plan is summarized in Figure 5.  
Bacteria Identification 
Bruker’s MALDI Biotyper Microbial Identification system allows for species 
level identification of bacteria within a few minutes and is based on MALDI-TOF MS. 
For the preliminary MALDI study, only the output samples from the experimental 
filtration method were tested.  The standard protocol for MALDI was followed with two 
different methods of sample preparation. The first method, straight testing, was done by 
spotting 1 µL of the filtered output sample directly onto the target plate. The second 
method, simple dilution, had 5 µL of the filtered output diluted with 5 µL of sterile 
deionized water, and 1 µL of the diluted sample was spotted onto the plate. Ten 










Passage of blood cells 
For initial samples processed using the TFF system, blood cells were observed in 
the output sample after filtration, as seen by a pink tint in the final bacteria suspension. 
This finding, along with confirmation under the microscope, indicated that the blood cells 
in the PBC were not completely excluded from the bacteria under the current system.  To 
quantitatively measure how many blood cells were eliminated with the bacteria into the 
permeate, a negative blood culture (NBC) was filtered under standard processing 
conditions with TEMs of different pore sizes. A NBC was created by adding 10 mL of 
bagged human blood to a BACTEC Standard Aerobic culture bottle to mimic the 
concentration of blood cells in a typical blood culture. Aliquots of 5 mL were removed 
from this NBC and filtered through filter membranes with pore sizes of 3, 2, and 1 µm in 
diameter. The standard processing parameters were used with a flow rate of 20 mL/min 
and a vacuum of –70 kPa. The permeate sample was diluted appropriately to improve 
ease of counting cells using a hemocytometer.  
With the 3 µm pore size, about 10% of the original number of RBCs in the NBC, 
corresponding to 5.63 x 108 total RBCs, were able to pass through the membrane. As the 
pore size decreased by 1 µm in diameter, about 10 times less RBCs were able to be 
extracted into the permeate each time (Figure 6A). As seen in both Figures 6 B and C, 
there are a number of pores on the membrane that overlap each other, resulting in larger 
pores that may allow unexpected particles to pass through the membrane. Figure 6C 
shows that the RBCs at rest are much larger than the 2 µm pores but are still able to pass 




were added to vary the ratio of standard media to lytic media while maintaining a 
constant concentration of blood cells and constant total volume. Turbidity measurements 
using a nephelometer with a McFarland standard were obtained every two seconds to see 
the change in turbidity over time. As seen in Figure 7, with increasing amounts of lytic 
media, the turbidity of the sample decreased to a minimum faster.  Lytic media itself has 
an optical density of about 0.2 McFarland which can help explain why the measured 
turbidity in this experiment does not decrease to 0 for all tested conditions. However, the 
most important observation is that there is a steep decrease in turbidity after saponin is 
added to the blood suspension.  
 
Figure 7. Turbidity of blood cell suspensions after addition of BD lytic media at different 
standard to lytic media ratios. The positive control was a blood cell suspension of 

























Turbidity of Lysed Blood Cells
Control (+) 1:1 1:2 1:5 1:10
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Bacteria recovery and loss 
The filtration process evolved early on in the project, taking into consideration 
different factors that would affect the efficiency and efficacy of the filtration system. 
Initially, the feed PBC solution was directly filtered through the membrane until a 
minimum amount of feed solution was remaining. Then, the addition of saline solution to 
the feed solution during filtration was implemented to allow for longer circulation of 
bacteria in the TFF system and dilution of the sample to promote hydrodynamic lift; this 
additional step was believed to allow for greater recovery of bacteria. Later on, the 
inclusion of a lysing step was needed to reduce the contribution of blood cells to the 
turbidity measurements used for the Phoenix AST system.  
A large scale study (n=83 bacterial strains) was performed for both Gram-
negative and Gram-positive bacteria to determine the recovery efficiency of the new PBC 
processing method. The PBC aliquots were processed through the filtration system with a 





so the retentate from that sample was recovered and a new filter was used for processing. 
Samples 2 and 3 were processed as normal using a new filter, but sample 4 reused the 
same filter used by sample 3 after a saline wash was done for that filter. Washing the 
filter used by sample 3 was believed to remove any bacteria remaining on the filter, but 
this assumption was proved to be false as shown in Figure 9. Here we incidentally have 
three conditions: (1) use of a new filter twice, for sample 1, (2) use of a new filter, for 
samples 2 and 3, and (3) reuse of an used filter, for sample 4. For samples 2 and 3 which 
were processed normally with a new filter, about 25% of the original number of bacteria 
in the PBC was recovered. However, 13% of bacteria in sample 1 was recovered using 
the new second filter and 40% of bacteria in sample 4 was recovered when reusing a 
filter. When performing a 2 sample t-test between samples 1 and 2, 1 and 3, 2 and 4, and 
3 and 4, the p-values were <0.0001, 0.010, 0.003 and 0.003, respectively.  
 
Figure 9. Recovery of S. aureus (29213) for 4 different samples to investigate filtration 
repeatability. Samples 2 and 3 used new filter membranes. Sample 1 used a new filter 
after the previous one was found faulty. The filter used for sample 3 was washed with 


























The different amounts of bacteria recovery from using filters of different 
conditions suggested that additional experiments were needed to investigate where 
bacteria loss occurred. Both Gram-negative (e.g. E. coli) and Gram-positive (S. aureus) 























































In Figures 10 A and B, the initial number of bacteria refers to the number of 
bacteria that was expected to be recovered in the final output. For the backwash sample, a 
small volume of saline (2 mL) was used to wash the filter membrane vigorously by 
pulsing the solution back and forth along the membrane. This step would potentially 
remove and recover any bacteria that may have reversibly attached to the membrane 
during the filtration process. In these two bacterial strains tested, there was about 25% of 
bacteria expected to be recovered that was lost for E. coli and 29% lost for S. aureus. 
Backwashing the filter expected to recover most of the bacteria remaining, but only a 
small fraction (4-8%) of the initial sample was recovered using that method. There was a 
strong possibility that bacteria were irreversibly bound to the filter membrane and hence 
could not be recovered by backwashing.  
 The above prediction could be confirmed by examining the membrane after 
filtration for any remaining bacteria. A 5 mL (0.72 McFarland) suspension of E. coli in 
saline was fluorescently stained with LIVE/DEAD BacLight Bacterial Viability Kit 
L7012 (Molecular Probes) by following the provided protocol. Then TFF was performed 
under normal processing conditions and the filter membrane was rinsed using saline 
solution to remove any bacteria on the surface that was not permanently attached.  By 
using a fluorescent microscope, Figure 11 shows that a noticeable number of bacteria was 
adhered to the membrane. A great degree of bacterial adhesion occurred despite the fact 
that there were less bacteria in the initial sample compared to what is expected in an 
actual PBC. As seen in previous experiments, the amount of E. coli in a typical PBC is 




Figure 11. Fluorescently stained E. coli on a hydrophilic polycarbonate TEM 
Mechanical processing of staphylococci samples prior to filtration 
Staphylococci such as S. aureus and S. epidermidis were found to have the lowest 
recovery after filtration compared to other Gram-positive organisms tested. This was 
mainly attributed to their tendency to form grape like clusters that are comparable in size 
to blood cells; the large size of the bacteria would prevent them from filtering through the 
membrane’s pores. Methods to attempt to break up the clusters into smaller units were 
tested to potentially increase recovery of these organisms. Chemical means such as the 
addition of detergents and physical means such as sonication did not show any apparent 
reduction in the size of the clusters.  
The microfluidic device seen in Figure 12 was originally developed by an 
academic lab and evaluated by BD Technologies to break apart solid tumor tissue. This 
device was then investigated for this project to see if it could be translated over to break 
up bacteria clusters as well. The microfluidic device has chambers with progressively 
smaller channels and constrictions which create areas of high shear stress, allowing for 
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mechanical disruption to break apart clusters of bacteria. A syringe pump was initially 
employed to push and pull the sample across the device for twenty cycles before the 
standard filtration procedure using TFF was performed.  
 
Figure 12. Microfluidic device evaluated to mechanically process and break up bacteria 
clusters. 
 
PBC samples containing organisms S. epidermidis C2106 and S. aureus C2052 
were processed using a syringe pump, whereas S. aureus 29213 was driven across the 
device using a vacuum pump. A vacuum pump was used in the latter sample to see if the 
PBC could be pulled across the channels at a faster speed, thus increasing the shear stress 
and potentially breaking up the staphylococci clusters into even smaller units. By 
employing the microfluidic device prior to standard filtration, the total number of bacteria 
recovered for organisms C2106, C2052, and 29213 increased by 156%, 132%, and 162% 
respectively, with p-values of 0.036, 0.013 and 0.083 from a paired t-test. The 
microfluidic device was effective in improving bacteria recovery for the staphylococci 




Figure 13. Comparison of bacteria recovery for Gram-positive organisms with and 
without mechanical processing prior to standard filtration with TFF. C2106 is S. 
epidermidis; C2052 and 29213 are S. aureus. (n=3 for each processing condition, per 
organism) 
 
Recovery of bacteria at different times after positivity  
One concern with the large bacteria recovery study was that such high recovery of 
bacteria was obtained from PBCs that were left in the BACTEC instrument to incubate 
for an additional 4-8 hours after positivity. Since the bacteria were allowed to grow 
further, these PBCs would have amounts of bacteria that were higher than they initially 
had when the bottle first went positive. Therefore, it might have been easier to recover a 
sufficient number of bacteria if there were more available initially. To investigate this 



































PBC sample at time zero when the bottle first went positive to that from processing the 
sample 6 hours after positivity. An aliquot of PBC was removed from the bottle at time 
zero and then the bottle was returned to the instrument to incubate for an additional six 
hours. We tested five strains each of Gram-negative and Gram-positive bacteria.  
 
Table 4. Gram-negative bacteria recovery for processing PBCs at different times after 
positivity 
 Total CFU recovered 
Organism Strain 0 hr after positivity 6 hr after positivity 
A. baumannii 19175 1.4E+09 1.0E+09 
K. pneumoniae 11060 9.0E+08 6.0E+09 
E. cloacae 17954 6.3E+08 4.0E+09 
E. coli 11046 8.5E+08 4.1E+09 
P. aeruginosa C2006 1.4E+09 2.2E+09 
 
Table 5. Gram-positive bacteria recovery for processing PBCs at different times after 
positivity 
 Total CFU recovered 
Organism Strain 0 hr after positivity 6 hr after positivity 
S. pneumoniae 3993 2.0E+07 1.9E+09 
S. epidermidis 3652 7.2E+08 1.2E+09 
S. aureus A29213 9.0E+07 2.6E+08 
E. faecalis A29212 1.1E+09 4.9E+09 
E. faecium A19434 1.6E+09 5.1E+08 
 
The total amount of bacteria that was recovered immediately after the PBC went 
positive compared to 6 hours afterwards is shown in Tables 4 and 5. In all cases, as 
expected, there was at least equal or more bacteria in the original PBC after further 
incubation post positivity (data not shown). Accordingly, in all cases, there was equal or 
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more bacteria recovered in the PBCs processed 6 hours after positivity. For the Gram-
negative organisms, samples processed soon after positivity recovered about 109 CFUs 
for each organism. However, for 2 of the 5 Gram-positive organisms tested, much less 
than 109 total CFUs were recovered and would therefore pose a problem for testing in 
MALDI ID.  
Integration with Phoenix for antimicrobial susceptibility testing 
  
 The filtered bacteria sample needed to be tested to ensure that it was compatible 
with the preexisting BD Phoenix AST system. Microbial samples from the two bacteria 
isolation methods being compared were integrated with the BD Phoenix system for AST. 
The two methods were (1) reference method using subcultivation and (2) new PBC 
processing method using filtration. For this study, 39 Gram-negative, 35 Gram-positive, 
and 10 streptococcus pneumoniae organisms were tested, with about 50/50 mix of wild 
type and resistant strains of bacteria across the 3 types, and 43 unique antimicrobials 
tested. Table 6 summarizes the essential agreement and categorical agreement between 
the two methods for different drug-organism combinations and Table 7 shows the same 
data separated by organism.  Essential agreement means that the MICs between the two 
methods compared are within ± 1 doubling dilution. Categorical agreement means that 
the susceptible, intermediate and resistant results between the two methods 
match.  Overall, the essential and categorical agreement is greater than 90% for both 
Gram negative and Gram-positive bacteria, but there are a few drug-bacteria 
combinations for the Gram-positive organisms that match in less than 90% of cases for 
categorical agreement (data shown in appendix). Although that is the case, those few 
drug-bacteria combinations match in at least 85% of cases for categorical agreement.  
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Table 6. BD Phoenix AST results for bacteria isolates from traditional subcultivation 
compared to PBC processing by filtration 






Gram Negative 845 99.9% 97.9% 
Gram Positive 699 99.0% 95.6% 
Streptococcus 140 99.3% 95.7% 
 
 
Table 7. BD Phoenix AST results for bacteria isolates from traditional subcultivation 
compared to PBC processing by filtration, separated by organism.  
 
 
Integration with MALDI for bacteria identification 
The potential to identify isolated bacteria from a filtered PBC using MALDI- 
TOF MS was evaluated in a preliminary study. For 11 different bacteria species, the 
processed output samples were prepared for MALDI using either the straight or diluted 
method and spotted two times onto the target plate, resulting in 44 total identifications. 
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The results outlined in Table 8 were based on the following interpretation of score values 
provided by the BioTyper software: score values ≥ 2.0 were regarded as correct 
identification at the species level, values between 1.7 and 1.99 were correct identification 
at the genus level, and score values < 1.7 were considered ‘not reliable identification’. 
Using the new PBC processing approach, MALDI-TOF MS identified 70% of all bacteria 
at the species level and 16% at the genus level. For Gram-negative bacteria, 80% were 
correctly identified at the species level and 10% at the genus level. Of the Gram-positive 
bacteria, identification was correct in 63% of cases at the species level and 21% at the 
genus level. For bacteria prepared using the straight method, 64% were correctly 
identified at the species level and 18% at the genus level, but for those prepared using the 
diluted method, 82% were correctly identified at the species level and 14% at the genus 
level. There were no misidentifications observed for this set of bacteria studied. Overall, 
the identification BioTyper score was higher for Gram-negative bacteria compared with 
Gram-positive bacteria, and for the samples that were diluted compared to those tested 
straight from the output tube. As seen in Figure 14, there is a positive correlation between 
the bacteria amount in the sample size tested and the score produced by the MALDI—the 
more bacteria present, the more reliable the results. The diluted sample has half the 
amount of salt and bacteria as its straight tested counterpart. For the diluted samples, 
there are no samples that give “not reliable identification”, but 18% of samples tested 
straight (4 out of 22) do, despite the fact that 3 out of 4 of those samples had enough 
bacteria spotted onto the target plate. From this preliminary data, a minimum bacteria 
amount of 6 x 105 is necessary to achieve a BioTyper score of ≥2 and the salt content in 
saline is not preferable for reliable results. The results show that these processed bacteria 
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samples were mostly appropriate for use with MALDI and able to provide at least genus 
level ID, but further studies are needed to determine what factors affect the ability to 
detect peaks in the instrument.  
 
Table 8. Preliminary MALDI results for 5 Gram negative and 5 Gram positive bacteria.  
Note: MALDI ID in bold is a genus level ID (score < 2.00).  
 






9908 E. coli Straight E. coli E. coli 5.0E+06 
Dilution E. coli E. coli 2.5E+06 
14780 K. pneumoniae Straight K. pneumoniae K. pneumoniae 7.0E+06 
Dilution K. pneumoniae K. pneumoniae 3.5E+06 
9926 E. cloacae Straight E. cloacae E. cloacae 3.8E+06 
Dilution E. cloacae E. cloacae 1.9E+06 
9915 P. aeruginosa Straight no peaks found P. aeruginosa 1.5E+06 
Dilution P. aeruginosa P. aeruginosa 7.3E+05 
9928 A. baumannii Straight no peaks found A. baumannii 1.2E+06 




3073 E. faecalis Straight E. faecalis E. faecalis 5.2E+06 
Dilution E. faecalis E. faecalis 2.6E+06 
C2101 S. saprophyticus Straight S. saprophyticus not reliable 
identification 
5.0E+05 
Dilution S. saprophyticus S. saprophyticus 2.5E+05 
7748 S. lugdunensis Straight S. lugdunensis S. lugdunensis 1.4E+06 
Dilution S. lugdunensis S. lugdunensis 7.1E+05 
3945 S. pneumoniae Straight S. pneumoniae no peaks found 1.1E+07 
Dilution S. pneumoniae S. pneumoniae 5.6E+06 
3993 S. pneumoniae Straight S. pneumoniae no peaks found 7.5E+04 
Dilution S. pneumoniae not reliable 
identification 
3.8E+04 
3998 S. pneumoniae Straight S. pneumoniae S. pneumoniae 6.3E+06 
































The aim of this project was to develop and optimize a new method to isolate 
bacteria from a PBC and evaluate the efficacy in producing an output sample to be used 
with subsequent ID and AST.  
Development of PBC processing method to isolate bacteria 
The first part of this project focused on understanding the cellularity of the sample 
produced by the TFF system. During the early development of the PBC processing 
procedure, the final output sample usually had a pink tint in color due to any RBCs that 
had passed through the filter. The color itself was not a problem, but this indicated that 
any blood cells remaining would contribute to the turbidity measurements used to 
inoculate AST panels. If the blood cells contributed significantly to the turbidity 
measurements, then there would be less bacteria than expected in the inoculated AST 
tube, thus affecting the accuracy of the AST results.  
As seen in Figure 6, the number of blood cells that passed through the 3 and 2 µm 
filters (about 107-108 CFUs) were found to be substantial compared to the total number of 
bacteria cells that were expected to be recovered (on the order of 107-109 CFUs). RBCs 
are widely understood to be deformable under certain flow conditions and thus were able 
to squeeze through the pores that are much smaller than the resting diameter of blood 
cells. The overlapping pores cannot be completely eliminated due to the inherent 
manufacturing process used to produce TEMs, but perhaps reducing the porosity of the 
membrane can reduce the likelihood of pores overlapping one another. Furthermore, 
diluting the feed sample during filtration can minimize cell-cell interaction and promote 
hydrodynamic lift, ensuring minimal contact of RBCs with the membrane surface.  
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Lysing the blood cells was a suitable option to address the presence of RBCs in 
the final sample.  When RBCs are lysed, their cell contents are released, leaving behind 
empty membrane sacks, and the opaque suspension of blood cells becomes transparent. 
The data in Figure 7 suggests that adding lytic media in a 1:1 volumetric ratio to the 
processed sample is sufficient to reduce the contribution of RBCs to the turbidity 
measurement to a minimal amount. By the addition of this step, the inoculation of the 
Phoenix AST panels with a known bacteria concentration is more accurate, therefore 
leading to more reliable AST results as well.  
Bacteria recovery and loss 
 This new bacteria isolation method using filtration needed to recover a minimum 
number of bacteria from PBCs to allow for use with ID and AST. There were no 
substantial problems regarding the recovery of the Gram-negative organisms tested in 
this study. However, less Gram-positive than Gram-negative bacteria were recovered 
from PBCs, resulting in inadequate amounts for downstream testing. Of the Gram-
positive organisms tested, E. faecalis, E. faecium and S. pneumoniae exist in chains 
whereas S. aureus and S. epidermidis exist as clusters. The morphology of the latter two 
can explain why it is more difficult for those two organisms to be filtered compared to the 
others. The chains along their shorter dimension can still pass through the membrane’s 
pores but sufficiently large clusters are unable to pass through.  
Although adequate bacteria were recovered in the final output sample from most 
PBCs, the question of where the bacteria were lost to arose. As suggested with the study 
using filter membranes of different conditions, there was potentially some bacteria loss 
due to adhesion of bacteria to the filter membrane or left remaining in the dead space in 
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the system. As seen in Figure 9, the transfer of sample 1 to a new filter after the original 
one was found faulty resulted in a significant loss of bacteria compared to the expected 
recovery amount seen with samples 2 and 3. This was anticipated because there was dead 
volume in the filter and additional solution was not used to wash off and recover any 
remaining bacteria from the first filter before transferring to the next one. For sample 4, 
using a filter that was believed to be thoroughly washed before its second use resulted in 
higher recovery than usual. There are two potential reasons for this observation: (1) The 
bacteria from the previous sample was not completely washed away; there was some 
dead space in the filter where bacteria from sample 3 accumulated and that bacteria were 
eluted with the newly recovered sample 4 during the second time the filter was used. (2) 
Bacteria from the previous use of the filter may be irreversibly attached to binding sites 
on the filter and saturated them, so that new bacteria from the new sample cannot adhere 
to those surfaces. Therefore, there would be less bacteria loss and more recovery for the 
following sample. In respect to the first reason, the geometry of the filter may have 
crevices that bacteria want to settle in. Especially as the isolated bacteria is concentrated 
to produce the final output sample, each drop of liquid left in the system can have 
millions of bacteria. Backwashing with a small volume of liquid was used to retrieve any 
potential bacteria remaining on the filter membrane and in the system, but even with that 
additional step, there was still a significant number of bacteria not accounted for. This 
further supports the second reason that there were some bacteria that were irreversibly 
bound to the filter membrane or any other materials used in the system. In future studies, 
multiple backwashing steps may be useful in determining how many bacteria are 
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reversibly attached to surfaces in the system and can be recovered until only the 
permanently attached bacteria are left. 
From the fluorescently stained bacteria sample in Figure 11, the image shows that 
substantial biofouling on the filter membrane occurred. However, this result may not be 
an accurate representation of how many bacteria would typically adhere to the membrane 
during processing. The cell suspension used had considerably less bacteria than what is 
typically found in a PBC and the degree of attachment may differ depending on the pore 
size of the filter.  Also, a suspension of bacteria in saline was filtered rather than a PBC 
with blood cells and other components that may affect the degree of adhesion. 
Nevertheless, further optimization of the filter geometry and/or membrane properties is 
necessary to reduce this bacterial adhesion and subsequent loss. As mentioned 
previously, the choice of materials used and their surface characteristics can potentially 
help to reduce this attachment and should be considered further.  
Another potential reason for less bacteria recovered than expected is the influence 
of high shear stress on microbial viability. There are studies that show that above a 
threshold value shear stress, the bacterial cells break, which is dependent not only on the 
microorganism species but also on the pump mechanism used to recirculate fluid during 
filtration. The viability loss was also influenced by the cellular concentration, number of 
passages through the shear stress device and exposure time. 40,41 Although this may not 
be likely as seen by promising AST results, confirmation by fluorescently staining the 
bacteria prior to filtration is possible to confirm the presence of dead cells in the final 
output sample.   
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Nature of initial PBC sample 
 The PBC processing approach was desired to be a universal method to process 
PBCs regardless of its initial condition. However, the results show that factors such as the 
original number of bacteria in the PBC and the type of bacteria present can affect 
recovery. Immediately after the blood culture bottle goes positive, there are less bacteria 
present compared to a sample that is allowed to incubate and grow further.  In the current 
workflow, if a blood culture bottle goes positive in the middle of the night when there are 
no laboratory personnel working, then the bottle would be left in the incubator for 
additional time until it can be processed. However, it is beneficial for PBCs to be 
processed as soon as possible to achieve faster time to results. If the PBC processing 
method was part of an automated system, then this filtration method would need to 
recover enough bacteria from a blood culture that had just turned positive. For the Gram-
negative organisms tested, there was sufficient bacteria recovered to perform further 
ID/AST testing even immediately after the bottle was flagged positive. However, some of 
the Gram-positive organisms had low and insufficient recovery from PBCs filtered 
shortly after positivity. To increase recovery, a mechanical method, such as the 
microfluidic device, can help break down Gram-positive bacteria clusters into smaller 
units prior to filtration so that they can be more readily extracted into the permeate. 
Another approach to increase the total bacteria recovered is to process a larger aliquot of 
PBC. The current method only uses 5 mL of PBC, so if recovery efficiency is similar for 
filtering larger volumes, more than enough bacteria should be recovered with up to 50 
mL of PBC that can be used.  
  
 43 
Integration with Phoenix AST and MALDI-TOF MS identification 
The Phoenix AST results in Table 6 show that the new PBC processing approach 
produced an isolated and viable bacteria sample that yielded comparable results to the 
conventional approach of subcultivation. The high degree of agreement between the two 
methods suggests that the viability of the bacteria was not compromised significantly and 
there was minimal interference of blood background in the inoculation of the AST panels. 
For the few drug-organism combinations that don’t match between the reference and 
experimental method, there could be a discrepancy between the number of bacteria that is 
expected in the 0.25 McFarland suspension and the amount that is actually inoculated due 
to the fact that turbidity measurements are estimations.  
 There are promising preliminary ID results using MALDI-TOF MS as shown in 
Table 8 and Figure 14. The suboptimal results can result from the presence of salt in the 
sample or insufficient number of bacteria spotted onto the MALDI target plate. MALDI 
is known to not prefer buffers, salts and detergents in the sample because it results in 
poor crystallization on the target plate and therefore interferes with the instrument 
readings.42,43 Further studies are needed to replace the saline washing buffer with a 
different solution that will maintain the viability of the bacteria and not affect the results 
from MALDI. For this set of Gram negative bacteria, some samples such as E. cloacae, 
P. aeruginosa and A. baumannii produced better results after dilution, possibly due to the 
fact that the salt concentration was too high in the initial output sample. For the Gram-
positive S. saprophyticus C2101 and S. pneumoniae 3993 strains, identification at the 
species level was not possible using the straight method nor with the diluted sample most 
probably due to too little bacteria present on the target plate. Especially for the S. 
pneumoniae 3993 sample, bacteria on the order of 104 CFU/µL was spotted onto the 
  
 44 
target plate, which is drastically less than the 106 CFUs required for MALDI. One way to 
mitigate the risk of having too little bacteria is to layer multiple spots to achieve enough 
bacteria for a good signal. A much more detailed and thorough investigation into how 
these factors such as bacteria amount and salt concentration affect MALDI results is 
necessary to improve the quality of ID with bacteria isolates. Furthermore, testing 
samples isolated from the reference method in addition to those from the experimental 
method will allow for a deeper understanding to see if it was possibly a sample or 
bacterial strain issue that led to suboptimal results.  
Proposed workflow 
A modified workflow for the routine processing of PBCs is proposed in Figure 
15. The initial Gram stain from a PBC will indicate if the sample is mono- or poly-
microbial; if the sample is poly-microbial, then this new PBC processing approach cannot 
be used and the conventional subcultivation step is needed. Furthermore, the Gram-stain 
decides if a mechanical processing step prior to filtration is necessary; Gram-positive 
organisms should be mechanically processed to increase the likelihood of recovering 
more bacteria. As seen in Figure 1, S. aureus and Coagulase negative staphylococci are 
the second and third most common bacteria present in PBCs, comprising of 13.60% and 
10.09% of all cases, respectively. Therefore, being able to recover suitable bacteria 
isolates from those PBCs is important due to their clinical prevalence. Then, after 
filtering the PBC sample and producing the bacteria isolate, ID and AST can be 
performed. Theoretically, by analyzing PBCs with this workflow, an ID result can be 
achieved on the day of positivity; the preliminary AST results can also potentially be 





This project proposes to shorten time to results in sepsis diagnostics by replacing 
the conventional subcultivation step with a fast and automated approach. For clinical 
adoption, the proposed method needs to be able to produce an isolated bacteria sample 
that can be subsequently used for both ID and AST. Processes that are time consuming 
and require multiple manual preparations are not suitable for clinical applications. For a 
bacteria isolation method to be utilized in clinical settings, the method needs to handle a 
wide range of samples regardless of bacteria species present among other components in 
the PBC.  
 The proposed TFF based approach to isolate bacteria from a PBC is an effective 
solution to yield viable bacteria that can replace the subcultivation step and eliminate 12-
24 hours in the PBC processing workflow. TFF is able to exclude at least 90% of blood 
cells from the isolated bacteria sample while recovering on average 3.4 x 109 total CFUs 
for Gram-negative organisms and 1.8 x 109 total CFUs for Gram-positive organisms.  
These viable bacteria isolates can be used for downstream testing since this method 
reduces the background that can contribute to inaccurate inoculation and results. This 
method is able to provide sufficient bacteria in most cases provided that workflow 
optimization is obtained. Direct testing of these bacteria isolates from blood culture gave 
a comparable performance for AST compared to the existing routine method of 
subcultivation. Based on the results of this study, the direct testing of filtered bacteria 
isolates with the BD Phoenix system could be confidently applied to AST of both Gram-
negative and Gram-positive bacteria without reverting to subcultivation as an alternative. 
ID and AST results were available on average 18 hours sooner, which would allow for 
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quicker adjustment of antimicrobial therapy. Therefore, this alternative method to isolate 
bacteria from a PBC would help to expedite optimized and targeted antibiotic treatment 
after bacteria is identified.  
 As alluded to earlier, further design optimization of this filtration system is 
needed to improve performance. Although this method is able to capture sufficient Gram-
negative bacteria, it is less effective in recovering Gram-positive organisms.  For the 
various reasons that may result in reduced bacteria recovery, including the nature of the 
PBC sample and the adhesion of bacteria to system components, there are proposed 
methods to address these issues. For example, the microfluidic chip for the mechanical 
processing of PBCs is a promising technique to increase recovery of Gram-positive 
organisms. Also, the filter geometry, membrane properties and system parameters can be 
modified to maximize organism recovery and filtration efficiency. In addition to the 
biofouling factors previously mentioned, some studies suggest that the membrane 
roughness and stiffness can also affect cell adhesion, so those properties can be 
considered for the membrane material of choice. 34,37 Furthermore, the two main system 
parameters, flow rate and TMP, can be optimized to reduce caking and maintain 
permeate flux.  
Compared to Bruker’s Sepsityper solution, this filtration approach is simpler to 
use and yields a sample that is more versatile for subsequent testing. With the new 
method, the isolated bacteria sample from PBC is viable, so it can be used for not only ID 
but also AST. The TFF principle can be adopted for an automated instrument and 
eventually the entire process from incubating a blood culture to obtaining ID and AST 
results can be hands-free. Therefore, this less labor-intensive process with reduced hands 
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on time is appealing to lab technicians. The current filtration process takes about 15 
minutes to complete, but any further reduction in time is beneficial since sepsis is a time-
critical condition. By reducing the amount of time to isolate bacteria, the PBC processing 
method facilitates faster time to results for ID and AST, which enables improved 




Table 1. Phoenix AST data for Gram negative bacteria-drug combinations 
 
  
DRUG	NAME TOTAL	n	= ESSENTIAL	AGREEMENT CATEGORICAL	AGREEMENT
Amikacin 39 100% 97.4%  (38)
Amoxicillin-Clavulanate 24 100% 95.8%  (23)
Ampicillin-Sulbactam 32 100% 96.9%  (31)
Aztreonam 31 100% 100%
Cefazolin 24 100% 100%
Cefepime 39 100% 97.4%  (38)
Cefoxitin 24 100% 91.7%  (22)
Ceftazidime 39 97.4%  (38) 94.9%  (37)
Ceftriaxone 32 100% 100%
Cefuroxime 24 100% 100%
Chloramphenicol 24 100% 100%
Ciprofloxacin 39 100% 97.4%  (38)
Colistin 15 100% 100%
Ertapenem 24 100% 100%
Fosfomycin w/G6P 8 100% 100%
Gentamicin 39 100% 97.4%  (38)
Imipenem 39 100% 97.4%  (38)
Levofloxacin 39 100% 100%
Meropenem 39 100% 100%
Minocycline 32 100% 96.9%  (31)
Moxifloxacin 18 100% 100%
Nitrofurantoin 24 100% 91.7%  (22)
Norfloxacin 31 100% 100%
Piperacillin-Tazobactam 39 100% 97.4%  (38)
Tetracycline 32 100% 93.8%  (30)
Tigecycline 24 100% 100%
Tobramycin 39 100% 97.4%  (38)
Trimethoprim-Sulfamethoxazole 32 100% 100%
ALL	DRUGS 845 99.9%		(844) 97.9%		(827)
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Table 2. Phoenix AST data for Gram positive bacteria-drug combinations 
 
  
DRUG	NAME TOTAL	n	= ESSENTIAL	AGREEMENT CATEGORICAL	AGREEMENT
Ampicillin 20 100% 100%
Amikacin 15 100% 93.3%  (14)
Chloramphenicol 35 100% 100%
Clindamycin 15 100% 100%
Ciprofloxacin 35 100% 85.7%  (30)
Ceftaroline 9 100% 88.9%  (8)
Daptomycin 34 100% 100%
Erythromycin 35 100% 94.3%  (33)
Fosfomycin 10 100% 90.0%  (1)
Nitrofurantoin 35 100% 88.6%  (31)
Gentamicin 15 100% 100%
Gentamicin-Synergy 20 100% 100%
Levofloxacin 34 100% 97.1%  (33)
Linezolid 35 100% 100%
Minocycline 35 100% 97.1%  (34)
Mupirocin-High Level 15 100% 100%
Moxifloxacin 25 96.0%  (24) 96.0%  (24)
Norfloxacin 34 97.1%  (33) 94.3%  (33)
Oxacillin 15 100% 100%
Penicillin G 35 97.1%  (34) 94.3%  (33)
Rifampin 35 97.1%  (34) 85.7%  (30)
Streptomycin-Synergy 20 100% 100%
Trimethoprim/Sulfamethoxazole 15 100% 100%
Tetracycline 35 100% 94.3%  (33)
Teicoplanin 34 94.1%  (32) 94.3%  (33)
Tigecycline 19 100% 100%
Vancomycin 35 97.1%  (34) 97.1%  (34)
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